These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 22221966
1. Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study). Migita K, Watanabe Y, Jiuchi Y, Nakamura Y, Saito A, Yagura M, Ohta H, Shimada M, Mita E, Hijioka T, Yamashita H, Takezaki E, Muro T, Sakai H, Nakamuta M, Abiru S, Komori A, Ito M, Yatsuhashi H, Nakamura M, Ishibashi H, Japanese NHO-Liver-network study group. Liver Int; 2012 May; 32(5):837-44. PubMed ID: 22221966 [Abstract] [Full Text] [Related]
9. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R. Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690 [Abstract] [Full Text] [Related]
12. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma. Mahmood S, Niiyama G, Kamei A, Izumi A, Nakata K, Ikeda H, Suehiro M, Kawanaka M, Togawa K, Yamada G. Liver Int; 2005 Apr 15; 25(2):220-5. PubMed ID: 15780042 [Abstract] [Full Text] [Related]
13. Emergency liver resection for ruptured hepatocellular carcinoma complicating cirrhosis. Chiappa A, Zbar A, Audisio RA, Paties C, Bertani E, Staudacher C. Hepatogastroenterology; 1999 Apr 15; 46(26):1145-50. PubMed ID: 10370682 [Abstract] [Full Text] [Related]
14. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, Gamboa-Domínguez A, Arrieta O. Clin Oncol (R Coll Radiol); 2007 Apr 15; 19(3):197-203. PubMed ID: 17359907 [Abstract] [Full Text] [Related]
15. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study. Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK, HEPNET. Greece Cohort Study Group. Gut; 2011 Aug 15; 60(8):1109-16. PubMed ID: 21270118 [Abstract] [Full Text] [Related]
18. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study. Makino Y, Shiraki K, Sugimoto K, Ito T, Yamanaka T, Fujikawa K, Takase K, Nakano T. Anticancer Res; 2000 Aug 15; 20(5C):3709-15. PubMed ID: 11268443 [Abstract] [Full Text] [Related]